• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管紧张素转换酶抑制剂的术前给药]

[Preoperative administration of angiotensin-converting enzyme inhibitors].

作者信息

Schirmer U, Schürmann W

机构信息

Abteilung Kardioanästhesiologie, Universitätsklinikum Ulm, Steinhövelstr. 9, 89075, Ulm.

出版信息

Anaesthesist. 2007 Jun;56(6):557-61. doi: 10.1007/s00101-007-1177-x.

DOI:10.1007/s00101-007-1177-x
PMID:17435976
Abstract

INTRODUCTION

The discussion about perioperative withdrawal or continuation of angiotensin-converting enzyme inhibitors (ACEI) remains controversial. Should it be continued to avoid peaks in blood pressure and heart rate during anesthesia? Or should it be discontinued the day before to avoid clinically relevant hypotonia? What is the greater risk? Since there are only a few studies dealing with this question, we compared the cardio-circulatory reaction during anesthesia after withdrawal and with continuation of ACEI therapy.

METHODS

A total of 100 hypertonic patients chronically treated with ACEIs were included in this prospective, randomized, double blind study. The last ACEI medication was given with the premedication in the morning (premed) or on the day before (withdrawal). Blood pressure and heart rate during induction and termination of anesthesia were compared between both groups. A threshold value for vasopressor therapy was determined to be a mean arterial pressure of 60 mmHg.

RESULTS

In the premed group Akrinor was necessary significantly more often and in higher dosages. Nevertheless, following induction the blood pressure and heart rates were significantly lower compared to the withdrawal group. The highest blood pressure and heart rate during induction and termination of anesthesia did not differ between the groups.

CONCLUSIONS

The continuation of ACEI therapy in the morning is not associated with a better control of blood pressure and heart rate but causes a more pronounced hypotension which forced a therapy more often. Patients chronically treated with ACEI should receive the ACEI the last time on the day before the operation and not with the premedication in the morning.

摘要

引言

关于围手术期停用或继续使用血管紧张素转换酶抑制剂(ACEI)的讨论仍存在争议。是应该继续使用以避免麻醉期间血压和心率峰值?还是应该在术前一天停药以避免出现临床相关的低血压?哪种风险更大?由于仅有少数研究涉及此问题,我们比较了停用ACEI治疗和继续使用ACEI治疗的患者在麻醉期间的心血管反应。

方法

本前瞻性、随机、双盲研究共纳入100例长期接受ACEI治疗的高血压患者。最后一剂ACEI药物在上午术前用药时给予(术前用药组)或在术前一天给予(停药组)。比较两组患者麻醉诱导期和结束时的血压和心率。将血管升压药治疗的阈值设定为平均动脉压60 mmHg。

结果

术前用药组使用阿克雷诺(Akrinor)的频率显著更高,剂量也更大。然而,与停药组相比,诱导后血压和心率显著更低。两组患者在麻醉诱导期和结束时的最高血压和心率无差异。

结论

上午继续使用ACEI治疗并不能更好地控制血压和心率,反而会导致更明显的低血压,从而更频繁地需要进行治疗。长期接受ACEI治疗的患者应在手术前一天最后一次服用ACEI,而不是在上午术前用药时服用。

相似文献

1
[Preoperative administration of angiotensin-converting enzyme inhibitors].[血管紧张素转换酶抑制剂的术前给药]
Anaesthesist. 2007 Jun;56(6):557-61. doi: 10.1007/s00101-007-1177-x.
2
Angiotensin system inhibitors in a general surgical population.普通外科人群中的血管紧张素系统抑制剂
Anesth Analg. 2005 Mar;100(3):636-644. doi: 10.1213/01.ANE.0000146521.68059.A1.
3
Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study.特利加压素联合麻黄碱与麻黄碱用于治疗长期接受血管紧张素转换酶抑制剂治疗患者麻醉诱导期低血压:一项前瞻性、随机、双盲、交叉研究。
Anesth Analg. 2002 Apr;94(4):835-40, table of contents. doi: 10.1097/00000539-200204000-00011.
4
The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists.长期接受血管紧张素II受体拮抗剂治疗的血管外科患者麻醉诱导的血流动力学效应。
Anesth Analg. 1999 Dec;89(6):1388-92. doi: 10.1097/00000539-199912000-00011.
5
Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors.长期接受血管紧张素转换酶抑制剂治疗的患者麻醉的血流动力学效应。
Anesth Analg. 1992 Jun;74(6):805-8. doi: 10.1213/00000539-199206000-00005.
6
Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.三重血管肽酶抑制对慢性植入仪器的无束缚清醒自发性高血压大鼠血流动力学特征的血管紧张素转换酶/中性内肽酶/内皮素转换酶活性的影响
J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S398-401. doi: 10.1097/01.fjc.0000166293.79948.09.
7
Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors.长期接受血管紧张素转换酶抑制剂治疗的患者在麻醉诱导时的心血管反应。
Can J Anaesth. 2000 May;47(5):433-40. doi: 10.1007/BF03018973.
8
Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production.血管紧张素转换酶抑制剂通过增加一氧化氮的产生增强丙泊酚的降压作用。
Free Radic Biol Med. 2018 Feb 1;115:10-17. doi: 10.1016/j.freeradbiomed.2017.11.010. Epub 2017 Nov 11.
9
Hemodynamic Changes after Continuing or Omitting Regular Angiotensin Converting Enzyme Inhibitors before Cataract Surgery: A Comparative Study.白内障术前继续或停用常规血管紧张素转换酶抑制剂后的血液动力学变化:一项比较研究。
Curr Hypertens Rev. 2023;19(1):59-65. doi: 10.2174/1573402119666230112110328.
10
The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.术前停用血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂在门诊和当天入院患者中高血压的风险。
Anesth Analg. 2014 May;118(5):938-44. doi: 10.1213/ANE.0000000000000076.

引用本文的文献

1
Effect of Surgical Position and Preoperative Antihypertensive Medication on the Incidence of Intraoperative Hypotension in Patients Undergoing Spine Surgery.手术体位及术前抗高血压药物对脊柱手术患者术中低血压发生率的影响
Anesth Pain Med. 2025 May 21;15(3):e161684. doi: 10.5812/aapm-161684. eCollection 2025 Jun 30.
2
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.围手术期局部缺血评估-3(POISE-3)的原理和设计:一项评估氨甲环酸和一种最小化非心脏手术低血压策略的随机对照试验。
Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1.
3

本文引用的文献

1
Perioperative management of chronic heart failure.
Anesth Analg. 2006 Sep;103(3):557-75. doi: 10.1213/01.ane.0000226099.60493.d9.
2
Angiotensin system inhibitors in a general surgical population.普通外科人群中的血管紧张素系统抑制剂
Anesth Analg. 2005 Mar;100(3):636-644. doi: 10.1213/01.ANE.0000146521.68059.A1.
3
Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics.特利加压素与去甲肾上腺素用于对抗接受肾素-血管紧张素系统抑制剂治疗患者的麻醉诱导性低血压:对全身和局部血流动力学的影响
Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial.
老年患者非心脏手术前停用与继续使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂:一项多中心随机对照试验的研究方案
Front Med (Lausanne). 2021 Mar 30;8:654700. doi: 10.3389/fmed.2021.654700. eCollection 2021.
4
Frequency of Intraoperative Hypotension After the Induction of Anesthesia in Hypertensive Patients with Preoperative Angiotensin-converting Enzyme Inhibitors.术前使用血管紧张素转换酶抑制剂的高血压患者麻醉诱导后术中低血压的发生率
Cureus. 2020 Jan 9;12(1):e6614. doi: 10.7759/cureus.6614.
5
Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial.心脏手术前血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂管理策略的比较:一项试点随机对照登记试验。
J Am Heart Assoc. 2018 Oct 16;7(20):e009917. doi: 10.1161/JAHA.118.009917.
6
Effect of pre-operative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists on intra-operative arterial pressures after induction of general anesthesia.术前停用血管紧张素转换酶抑制剂或血管紧张素II受体拮抗剂对全身麻醉诱导后术中动脉压的影响。
Anesth Essays Res. 2014 Jan-Apr;8(1):32-5. doi: 10.4103/0259-1162.128903.
Anesthesiology. 2005 Jan;102(1):12-9. doi: 10.1097/00000542-200501000-00006.
4
ACE inhibition does not exaggerate the blood pressure decrease in the early phase of spinal anaesthesia.血管紧张素转换酶抑制剂不会夸大脊髓麻醉早期的血压下降。
Acta Anaesthesiol Scand. 2003 Aug;47(7):891-6. doi: 10.1034/j.1399-6576.2003.00175.x.
5
Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.冠状动脉搭桥手术后并发左心室功能不全时静脉注射依那普利拉的有益血流动力学和肾脏效应。
Crit Care Med. 2003 May;31(5):1421-8. doi: 10.1097/01.CCM.0000063050.66813.39.
6
Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors.特利加压素与去甲肾上腺素用于纠正长期接受肾素-血管紧张素系统抑制剂治疗的患者全身麻醉后难治性动脉低血压。
Anesthesiology. 2003 Jun;98(6):1338-44. doi: 10.1097/00000542-200306000-00007.
7
Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice.血管紧张素转换酶抑制剂:作用机制及其在麻醉实践中的意义。
Curr Pharm Des. 2003;9(9):763-76. doi: 10.2174/1381612033455413.
8
Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study.特利加压素联合麻黄碱与麻黄碱用于治疗长期接受血管紧张素转换酶抑制剂治疗患者麻醉诱导期低血压:一项前瞻性、随机、双盲、交叉研究。
Anesth Analg. 2002 Apr;94(4):835-40, table of contents. doi: 10.1097/00000539-200204000-00011.
9
The role of the renin-angiotensin system in the development of cardiovascular disease.肾素-血管紧张素系统在心血管疾病发展中的作用。
Am J Cardiol. 2002 Jan 24;89(2A):3A-9A; discussion 10A. doi: 10.1016/s0002-9149(01)02321-9.
10
Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction.
Br J Anaesth. 2001 Feb;86(2):169-75. doi: 10.1093/bja/86.2.169.